Insider Transactions in Q2 2022 at Tff Pharmaceuticals, Inc. (TFFP)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
Harlan F Weisman President and CEO |
BUY
Open market or private purchase
|
Direct |
4,615
+24.0%
|
$23,075
$5.5 P/Share
|
|
May 18
2022
|
Harlan F Weisman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+20.0%
|
$12,500
$5.12 P/Share
|
|
May 17
2022
|
Kirk Allen Coleman Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
425
+10.37%
|
$1,700
$4.83 P/Share
|
|
May 17
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
24,600
+18.33%
|
$123,000
$5.08 P/Share
|
|
May 16
2022
|
Stephen Rocamboli Director |
BUY
Open market or private purchase
|
Direct |
3,000
+13.81%
|
$12,000
$4.54 P/Share
|
|
May 16
2022
|
Glenn R. Mattes President and CEO |
BUY
Open market or private purchase
|
Direct |
16,000
+30.77%
|
$64,000
$4.78 P/Share
|
|
May 16
2022
|
Kirk Allen Coleman Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+27.78%
|
$5,000
$4.4 P/Share
|
|
May 16
2022
|
Harlan F Weisman President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+25.0%
|
$10,000
$4.74 P/Share
|
|
May 16
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
85,000
+50.0%
|
$340,000
$4.86 P/Share
|
|
Apr 04
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
542,000
+28.6%
|
$3,252,000
$6.66 P/Share
|